283 related articles for article (PubMed ID: 17372625)
1. HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
Chien CV
PLoS One; 2007 Mar; 2(3):e278. PubMed ID: 17372625
[TBL] [Abstract][Full Text] [Related]
2. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA
PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145
[TBL] [Abstract][Full Text] [Related]
3. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Pinheiro Edos S; Antunes OA; Fortunak JM
Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
[TBL] [Abstract][Full Text] [Related]
4. A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries.
Waning B; Diedrichsen E; Moon S
J Int AIDS Soc; 2010 Sep; 13():35. PubMed ID: 20840741
[TBL] [Abstract][Full Text] [Related]
5. Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs.
Holmes CB; Coggin W; Jamieson D; Mihm H; Granich R; Savio P; Hope M; Ryan C; Moloney-Kitts M; Goosby EP; Dybul M
JAMA; 2010 Jul; 304(3):313-20. PubMed ID: 20639565
[TBL] [Abstract][Full Text] [Related]
6. Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?
Meiners C; Sagaon-Teyssier L; Hasenclever L; Moatti JP
PLoS One; 2011; 6(8):e23478. PubMed ID: 21858138
[TBL] [Abstract][Full Text] [Related]
7. AIDS meeting. Companies, donors pledge to close gap in AIDS treatment.
Cohen J
Science; 2000 Jul; 289(5478):368-9. PubMed ID: 10939936
[TBL] [Abstract][Full Text] [Related]
8. Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) - A Strategic Option for India.
Satyanarayana K; Srivastava S
Open AIDS J; 2010 Jan; 4():41-53. PubMed ID: 20148091
[TBL] [Abstract][Full Text] [Related]
9. Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America.
Wirtz VJ; Santa-Ana-Tellez Y; Trout CH; Kaplan WA
Health Policy Plan; 2012 Dec; 27(8):638-48. PubMed ID: 22367770
[TBL] [Abstract][Full Text] [Related]
10. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.
Waning B; Diedrichsen E; Jambert E; Bärnighausen T; Li Y; Pouw M; Moon S
BMC Pediatr; 2010 Oct; 10():74. PubMed ID: 20950492
[TBL] [Abstract][Full Text] [Related]
11. Global patent police block cost-reduction efforts.
Kasper T
GMHC Treat Issues; 1999 Mar; 13(3):1-2. PubMed ID: 11366201
[TBL] [Abstract][Full Text] [Related]
12. Prices of second-line antiretroviral treatment for middle-income countries inside versus outside sub-Saharan Africa.
Simmons B; Hill A; Ford N; Ruxrungtham K; Ananworanich J
J Int AIDS Soc; 2014; 17(4 Suppl 3):19604. PubMed ID: 25394108
[TBL] [Abstract][Full Text] [Related]
13. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.
Venkatesh KK; Mayer KH; Carpenter CC
Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332
[TBL] [Abstract][Full Text] [Related]
14. Generic and branded drugs for the treatment of people living with HIV/AIDS.
Bartlett JA; Muro EP
J Int Assoc Physicians AIDS Care (Chic); 2007 Mar; 6(1):15-23. PubMed ID: 17329500
[TBL] [Abstract][Full Text] [Related]
15. Examining the production costs of antiretroviral drugs.
Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J
AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939
[TBL] [Abstract][Full Text] [Related]
16. Trends and economic stress: a challenge to universal access to antiretroviral treatment in India.
Dhamija P; Bansal D; Medhi B
Curr HIV Res; 2009 Jul; 7(4):410-7. PubMed ID: 19601776
[TBL] [Abstract][Full Text] [Related]
17. Affordability of adult HIV/AIDS treatment in developing countries: modelling price determinants for a better insight of the market functioning.
Sagaon-Teyssier L; Singh S; Dongmo-Nguimfack B; Moatti JP
J Int AIDS Soc; 2016; 19(1):20619. PubMed ID: 27765142
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study - PEDA Study.
Sapsirisavat V; Vongsutilers V; Thammajaruk N; Pussadee K; Riyaten P; Kerr S; Avihingsanon A; Phanuphak P; Ruxrungtham K;
PLoS One; 2016; 11(6):e0157039. PubMed ID: 27322409
[TBL] [Abstract][Full Text] [Related]
19. Cut-rate AIDS.
Golden F
Time; 2001 Mar; 157(11):68. PubMed ID: 11276822
[No Abstract] [Full Text] [Related]
20. Preventing antiretroviral anarchy in sub-Saharan Africa.
Harries AD; Nyangulu DS; Hargreaves NJ; Kaluwa O; Salaniponi FM
Lancet; 2001 Aug; 358(9279):410-4. PubMed ID: 11502341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
